Results 81 to 90 of about 2,835,481 (302)
Reconstructing enzyme evolution by protein engineering
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler +2 more
wiley +1 more source
Yuandani,1,2 Ibrahim Jantan,1 Menaga Ilangkovan,1 Khairana Husain,1 Kok Meng Chan3 1Drug and Herbal Research Center, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia; 2Falkultas Farmasi, Universitas
Chan KM +4 more
core
Minimum and fractional inhibitory concentrations of compounds against Streptomyces scabies PS07.
Minimum and fractional inhibitory concentrations of compounds against Streptomyces scabies PS07.
Chih Lin (5146691) +6 more
core +1 more source
Investigating transcription factor dynamics in health and disease using FRAP
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj +3 more
wiley +1 more source
Thirteen novel 1,2,3-triazole linked nucleobases (5a-m) were designed and efficiently synthesized as potential human enzyme inhibitors. The target compounds were synthesized by using Copper (I)-catalysed Huisgen-Sharpless-Meldal 1,3-dipolar cycloaddition
Aditya Aggarwal +4 more
doaj +1 more source
Guiera senegalensis J.F. Gmel. (Combretaceae) is commonly used as a traditional medicine in Africa. In our previous study, the hydro-alcoholic extracts of the leaves of G.
Amina Ibrahim Dirar +5 more
doaj +1 more source
In-silico inhibitory potential of the three compounds against DNA gyrase.
In-silico inhibitory potential of the three compounds against DNA gyrase.
Ifeoma B. Ujam (3686578) +3 more
core +1 more source
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source
Minimum inhibitory concentration (MIC) of rhodanine compounds against Candida albicans.
Minimum inhibitory concentration (MIC) of rhodanine compounds against Candida albicans.
Charles R. Ashby Jr (369799) +4 more
core +1 more source
Structure‐forward targeting of claudins with synthetic binders
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source

